Impact of the New Metabolic-Associated Fatty Liver Disease (MAFLD) on NAFLD Patients Classification in Italy

Clin Gastroenterol Hepatol. 2021 Dec;19(12):2683-2684. doi: 10.1016/j.cgh.2021.02.015. Epub 2021 Feb 10.

Authors

Francesco Angelico¹, Daniele Pastori², Maria Del Ben³

Affiliations

¹ Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
² Emergency Medicine Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.
³ I Clinica Medica, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University, Rome, Italy.

PMID: 33581358
DOI: 10.1016/j.cgh.2021.02.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Italy / epidemiology
Metabolic Syndrome*
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / epidemiology